Blood Journal
Leading the way in experimental and clinical research in hematology

HLA-haploidentical bone marrow transplantation with post-transplant cyclophosphamide expands the donor pool for patients with sickle cell disease

  1. Javier Bolaños-Meade1,*,
  2. Ephraim J. Fuchs1,
  3. Leo Luznik1,
  4. Sophie M. Lanzkron2,
  5. Christopher J. Gamper3,
  6. Richard J. Jones1, and
  7. Robert A. Brodsky2
  1. 1 Hematologic Malignancies and Bone Marrow Transplantation Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD, United States;
  2. 2 Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States;
  3. 3 Division of Pediatric Oncology, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD, United States
  1. * Corresponding author; email: fbolano2{at}jhmi.edu
PDF Container